SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-19-012478
Filing Date
2019-11-07
Accepted
2019-11-07 15:59:49
Documents
2
Period of Report
2019-11-07
Effectiveness Date
2019-11-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A azrxdef14a_nov72019.htm DEF 14A 605409
2 IMAGE azrx.jpg GRAPHIC 4554
  Complete submission text file 0001654954-19-012478.txt   612935
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37853 | Film No.: 191200154
SIC: 2834 Pharmaceutical Preparations